CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-08 | Maduck Sean See Remarks | Gift | −34,000 | 5,147 | ||
| 2026-01-08 | Maduck Sean See Remarks | Other acquisition | +34,000 | 34,000 | ||
| 2026-01-06 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +20,000 | $21.65 | $433K | 21,235 |
| 2026-01-06 | Guyer William Chief Development Officer | Sale 10b5-1 | −20,000 | $35.18 | $704K | 1,235 |
| 2026-01-06 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 250,000 | ||
| 2026-01-01 | BAKER G LEONARD JR Director | Gift | −0 | 3,308,303 | ||
| 2025-12-24 | Robb Gary Charles Chief Business Officer | Option exercise | +145,000 | $3.88 | $563K | 158,910 |
| 2025-12-24 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −80,284 | $83.59 | $6.7M | 78,626 |
| 2025-12-24 | Robb Gary Charles Chief Business Officer | Option exercise · Stock option (right to buy) | −145,000 | 0 | ||
| 2025-12-24 | BELANOFF JOSEPH K Chief Executive Officer | Option exercise | +550,000 | $3.88 | $2.1M | 550,000 |
| 2025-12-24 | BELANOFF JOSEPH K Chief Executive Officer | Shares withheld for taxes | −306,846 | $83.59 | $25.6M | 243,154 |
| 2025-12-24 | BELANOFF JOSEPH K Chief Executive Officer | Gift | −243,154 | 0 | ||
| 2025-12-24 | BELANOFF JOSEPH K Chief Executive Officer | Other acquisition | +243,154 | 2,944,524 | ||
| 2025-12-24 | BELANOFF JOSEPH K Chief Executive Officer | Option exercise · Stock option (right to buy) | −550,000 | 0 | ||
| 2025-12-12 | WILSON JAMES N Director | Gift | −400,000 | 1,045,168 | ||
| 2025-12-12 | WILSON JAMES N Director | Other acquisition | +200,000 | 200,000 | ||
| 2025-12-12 | WILSON JAMES N Director | Other acquisition | +200,000 | 200,000 | ||
| 2025-12-02 | Guyer William Chief Development Officer | Gift 10b5-1 | −787 | 0 | ||
| 2025-12-02 | Guyer William Chief Development Officer | Other acquisition 10b5-1 | +787 | 1,235 | ||
| 2025-12-02 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +20,000 | $21.65 | $433K | 21,235 |
Page 15 of 61 · 1,220 trades